Our breast cancer blood Test is targeting a large population of women that need to be checked regularly for breast cancer, whether that is because of a high risk group or at an age that women are routinely screened.

Usually all women above 40 years old undergo a breast testing. The recommended testing protocol using Mammography and Ultrasound have their limitations and discomfort. Our proprietary TM-B1 cancer test will support current cancer diagnostic protocols in their weak points (like dense breast tissue and young woman) and give a simple and low-cost solution for early detection. Our proprietary TM-B2 cancer screen will allow health care providers to distinguish between benign and malignant breast tumors.